Indo Rama Synthetics Q1 Results: Profit Rises YoY on Strong Margin Expansion
Indo Rama Synthetics posted Q1 consolidated net profit of 637M rupees, up from 528M rupees YoY, despite revenue falling to 9.37B rupees from 13.1B rupees due to geopolitical headwinds. EBITDA rose sharply to 1.45B rupees from 970M rupees, with EBITDA margin expanding to 15.57% from 7.43%, underscoring strong margin-led performance. The Board also approved key leadership re-appointments and corporate governance updates ahead of the 40th AGM.

*this image is generated using AI for illustrative purposes only.
Indo Rama Synthetics reported a consolidated net profit of 637M rupees for Q1, marking a year-on-year increase from 528M rupees in the prior year quarter. Despite a decline in total revenue to 9.37B rupees from 13.1B rupees YoY, driven by volume impacts from West Asia geo-political issues, the company significantly expanded its EBITDA margin to 15.57% from 7.43% in the prior year quarter, reflecting improved product mix and resilient operational execution amid volatile market conditions.
The Board of Directors, meeting on July 29, 2026, approved the unaudited standalone and consolidated financial results as reviewed by statutory auditors SS Kothari Mehta & Co. LLP. In compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company disclosed these outcomes alongside corporate governance updates. The Board also amended the notice for the 40th Annual General Meeting, scheduled for September 8, 2026, due to changes in board composition.
Consolidated Financial Performance
The company's operational efficiency improved significantly despite lower top-line performance. EBITDA rose to 1.45B rupees from 970M rupees in the prior year quarter, reflecting strong cost management and a favourable product mix. Standalone net profit stood at ₹33.75 crore, up from ₹32.31 crore in the same period last year. Finance costs decreased slightly to ₹29.38 crore from ₹29.03 crore in the prior year quarter, while foreign exchange fluctuation losses remained contained at ₹2.91 crore.
The following table summarises the key consolidated financial metrics for the quarter:
| Particulars: | Q1FY27 | Q1FY26 |
|---|---|---|
| Total Revenue | 9.37B Rupees | 13.1B Rupees |
| EBITDA | 1.45B Rupees | 970M Rupees |
| EBITDA Margin (%) | 15.57% | 7.43% |
| Net Profit | 637M Rupees | 528M Rupees |
Corporate Governance Updates
The Board re-constituted the Stakeholders Relationship Committee under Section 178 of the Companies Act, 2013, appointing Mr. Ravi Capoor as Chairman. Key committee members include Executive Directors Om Prakash Lohia and Vishal Lohia, Whole-time Director Sanjay Gupta, Non-executive Non-Independent Director Vipin Kumar, and Independent Director Atim Kabra.
Leadership Re-appointments
Subject to shareholder approval at the upcoming AGM, the Board approved the following re-appointments:
- Om Prakash Lohia: Re-appointed as Chairman and Managing Director for three years, effective December 26, 2026, to December 25, 2029.
- Dharmpal Agarwal: Re-appointed as Independent Director for five consecutive years, effective November 25, 2026, to November 24, 2031.
What the Numbers Show
The divergence between declining revenue and rising profitability highlights a margin-led performance strategy. While total revenue fell YoY due to external geopolitical headwinds affecting volumes, the EBITDA margin expanded substantially by over 800 basis points. This reflects Indo Rama's ability to mitigate cost pressures through product mix optimisation, enabling higher absolute profits despite a smaller sales base. The stability in finance costs further supported bottom-line resilience.
Historical Stock Returns for Indo Rama Synthetics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.73% | +6.84% | +18.63% | +19.45% | +6.74% | +1.70% |
How might the ongoing geopolitical instability in West Asia impact Indo Rama Synthetics' export volumes and revenue recovery in Q2FY27?
Can the company sustain its expanded EBITDA margins of 15.57% if raw material costs rise or if the favorable product mix normalizes?
What specific operational strategies is management employing to offset the significant year-on-year revenue decline while maintaining profit growth?


































